文献速递创伤与烧伤重症综合管理与镇静镇痛

骨科创伤出院后静脉血栓栓塞预防的依从性:阿司匹林与低分子肝素随机对照试验结果

Post-discharge adherence with venous thromboembolism prophylaxis after orthopedic trauma: Results from a randomized controlled trial of aspirin versus low molecular weight heparin.
PubMed 文献 · J Trauma Acute Care Surg · 2018-01-01
一句话结论骨科创伤患者出院后VTE预防总体依从性高(平均MMAS 7.2/8),阿司匹林与低分子肝素方案依从性相似,但低分子肝素组更易感到方案困扰。

该随机对照试验纳入需VTE预防的成人创伤患者(上肢或下肢骨折需手术或任何骨盆/髋臼骨折),随机接受低分子肝素30 mg每日两次或阿司匹林81 mg每日两次。出院后10至21天通过Morisky药物依从性量表(MMAS-8)评估依从性,150例完成问卷(低分子肝素64例,阿司匹林86例)。总体依从性高(平均MMAS 7.2/8,SD 1.5),两方案相似(低分子肝素7.4 vs 阿司匹林7.0,p=0.13)。低分子肝素组更常感到方案困扰(23% vs 9%,p=0.02)。多因素模型显示低-中等依从性与使用低分子肝素(aOR 2.34,CI 1.06-5.18)、需自行给药(aOR 4.44,CI 1.45-13.61)、男性(aOR 2.46,CI 1.10-5.49)及较年轻年龄(每增加10岁aOR 0.72,CI 0.57-0.91)相关。

要点

  • 骨科创伤出院后VTE预防总体依从性高,平均MMAS 7.2/8(SD 1.5),低分子肝素组7.4 vs 阿司匹林组7.0,差异无统计学显著(p=0.13)。
  • 低分子肝素组患者更常感到方案困扰(23% vs 9%,p=0.02)。
  • 低-中等依从性与使用低分子肝素(aOR 2.34,CI 1.06-5.18)、需自行给药(aOR 4.44,CI 1.45-13.61)、男性(aOR 2.46,CI 1.10-5.49)及较年轻年龄(每增加10岁aOR 0.72,CI 0.57-0.91)相关。
  • 作者认为在管理患者和设计疗效试验时应考虑这些影响依从性的因素。

适用人群与场景

  • 成人创伤患者,具有需手术的肢体骨折或任何骨盆/髋臼骨折,需要VTE预防。

处置流程与药物剂量

  • 随机接受低分子肝素30 mg每日两次或阿司匹林81 mg每日两次。
  • 出院后10至21天通过Morisky药物依从性量表(MMAS-8)评估依从性。

研究设计与关键结果

  • 随机对照试验,150例完成问卷(低分子肝素64例,阿司匹林86例)。
  • 总体依从性高(平均MMAS 7.2/8,SD 1.5),两方案相似(低分子肝素7.4 vs 阿司匹林7.0,p=0.13)。
  • 低分子肝素组更常感到方案困扰(23% vs 9%,p=0.02)。
  • 低-中等依从性与使用低分子肝素(aOR 2.34,CI 1.06-5.18,p=0.04)、需自行给药(aOR 4.44,CI 1.45-13.61,p<0.01)、男性(aOR 2.46,CI 1.10-5.49,p=0.03)及较年轻年龄(每增加10岁aOR 0.72,CI 0.57-0.91,p<0.01)相关。

证据类型、等级与局限

  • 证据类型:随机对照试验;证据等级:治疗性,II级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为在管理患者和设计疗效试验时应考虑与依从性降低相关的因素(使用低分子肝素、需自行给药、男性、较年轻年龄)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Orthopedic trauma patients are often treated with venous thromboembolism (VTE) chemoprophylaxis with aspirin or low molecular weight heparin (LMWH) after discharge from their index admission, but adherence patterns are not known. We hypothesized that overall adherence would be moderate and greater with aspirin compared to LMWH.

METHODS: We conducted a randomized controlled trial of adult trauma patients with an operative extremity fracture or any pelvic/acetabular fracture requiring VTE prophylaxis. Patients were randomized to receive either LMWH 30 mg BID or aspirin 81 mg BID. Patients prescribed outpatient prophylaxis were contacted between 10 and 21 days after discharge to assess adherence measured by the validated Morisky Medication Adherence Scale (MMAS-8). Adherence scores were compared between the two treatment arms with similar results for intention-to-treat and as-treated analyses. As-treated multivariable logistic regression was performed to determine factors associated with low-medium adherence scores.

RESULTS: One hundred fifty patients (64 on LMWH, 86 on aspirin) on chemoprophylaxis at time of follow-up completed the questionnaire. As-treated analysis showed that adherence was high overall (mean MMAS 7.2 out of 8, SD 1.5) and similar for the two regimens (LMWH: 7.4 vs. aspirin: 7.0, p = 0.13). However, patients on LMWH were more likely to feel hassled by their regimen (23% vs. 9%, p = 0.02). In a multivariable model, low-medium adherence was associated with taking LMWH as the prophylaxis medication (aOR 2.34, CI 1.06-5.18, p = 0.04), having to self-administer the prophylaxis (aOR 4.44, CI 1.45-13.61, p < 0.01), being of male sex (aOR 2.46, CI 1.10-5.49, p = 0.03), and of younger age (aOR 0.72 per additional 10 years of age, CI 0.57-0.91, p < 0.01).

CONCLUSIONS: Overall post-discharge adherence with VTE prophylaxis was high. Several factors, including prophylaxis by LMWH, were associated with decreased adherence. These factors should be considered when managing patients and designing efficacy trials.

LEVEL OF EVIDENCE: Therapeutic, level II.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Haac BE, Van Besien R, O'Hara NN, et al. Post-discharge adherence with venous thromboembolism prophylaxis after orthopedic trauma: Results from a randomized controlled trial of aspirin versus low molecular weight heparin. J Trauma Acute Care Surg. 2018. PMID: 29251700. doi:10.1097/TA.0000000000001771

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。